FDA Nod For Roche’s Columvi Brings Third Anti-CD20 Bispecific To Market

 
• By Alaric DeArment
  
Roche's Genentech won FDA accelerated approval for Columvi in DLBCL • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip